The total price of the acquisition was $4.9 billion in cash and 144.3 million common shares with fair value of $10.7 billion.[2] Walgreens had previously purchased 45% of the company for $4.0 billion and 83.4 million common shares in August 2012 with an option to purchase the remaining shares within three years.[3] Walgreens became a subsidiary of the newly created company after the transactions were completed.[4]